Filing Flows › Conmed (CNMD) › Q1 2026
Conmed (CNMD) Q1 2026 earnings results (first quarter 2026)
10-Q filed Apr 30, 2026
Conmed (CNMD) reported revenue of $317M for the first quarter 2026 (Q1 2026), -1% from a year earlier and -15% from the quarter before. Operating margin was 8.0%, net earnings $13.8M (4.4% of revenue).
Conmed, Q1 2026: revenue $317M (-1% year over year), operating margin 8.0%, net earnings $13.8M, operating cash flow $13.5M. The chart follows the revenue to costs, profit and cash.
| Q1 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $317M | -15% | -1% |
| Gross profit | $183M | -16% | +3% |
| Operating profit | $25.4M | -31% | +59% |
| Net earnings | $13.8M | -17% | +129% |
| Operating cash flow | $13.5M | -71% | -68% |
| Free cash flow | $10.6M | -74% | -72% |
What changed
Revenue was $317.0M in Q1 2026, down 1% year over year and down 15% from the previous quarter. General Surgery was the largest line at 53% of revenue. General Surgery lost $13.6M year over year (down 7%), 323% of the total change.
Gross margin was 57.9%, up 2.5 points from Q1 2025. Operating profit was $25.4M, a 8.0% margin (up 3.0 points year over year). Operating expenses fell 2% while revenue fell 1%. The fastest-growing cost line was Research & development (+26%). Net earnings were $13.8M, up 129% year over year. The effective tax rate was 24.7%.
Operating cash flow was $13.5M (down 68% year over year), 97% of net earnings. Non-cash charges added back $12.9M of depreciation and amortization and $5.5M of share-based compensation. Working capital and other items used $18.7M. Capital expenditures of $2.9M left free cash flow of $10.6M.
Questions
What was Conmed's revenue in the first quarter 2026?
Conmed (CNMD) reported revenue of $317M for the first quarter 2026 (Q1 2026), -1% from a year earlier and -15% from the quarter before.
Was Conmed profitable in the first quarter 2026?
Operating profit was $25.4M (8.0% of revenue) and net earnings $13.8M.
Source: Conmed 10-Q on SEC EDGAR.